Aarti Drugs Limited — Call Transcript 2020

Jul 24, 2020

==> picture [477 x 82] intentionally omitted <==

Ref: ADL/SE/2020-21 July 24, 2020

To, Listing/ Compliance Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001

To, Listing/ Compliance Department National Stock Exchange of India Limited, “Exchange Plaza”, Bandra - Kurla Complex, Bandra (E), Mumbai – 400051

BSE CODE – 524348

NSE SYMBOL: AARTIDRUGS

Dear Sir/Madam,

Ref : Regulation 30(6) of SEBI (LODR) Regulations, 2015 Sub: Intimation of Conference Call

This is to inform you that Quarterly Conference Call for the Investors and Analysts has been scheduled on Monday, July 27, 2020 at 3:00 PM IST to discuss the Company’s Q1 FY21 Results. Please find attached herewith invitation for the same.

Kindly take the same on record.

Thanking you,

Yours faithfully,

FOR AARTI DRUGS LIMITED

==> picture [88 x 35] intentionally omitted <==

RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: A54527

==> picture [468 x 32] intentionally omitted <==

Centrum Broking Limited Cordially invites you to a

Conference Call

with Management of

Aarti Drugs Ltd.

Agenda: Discussion on Q1FY21 results & future outlook

Company Management

		Company Management
		Mr. Harshit Savla		Jt. Managing	Director
		Mr. Harit Shah		Wholetime Director
		Mr. Adhish Patil		CFO
		Express Login		Diamond Pass Registration
		Audio Link Information		Click here
		Recording Id		CEN0220200727122654
		Conference Dial-In Numbers
		Primary Number:		+91 22 6280 1210 / +91 22 7115 8111
		Secondary Number:		+91 70456 71221
				USA	: 1 866 746 2133
		International Toll Free Numbers:		UKSingapore	: 0 808 101 1573: 800 101 2045
				Hong Kong	: 800 964 448
		Date:		Monday, 27 July2020
		Time:		3.00 PM IST
		RSVP:
		Ms. Cyndrella Carvalho
		Centrum Broking Limited
		Land line: +91 22 4215 9643
		Mob: +91 9823 615656
		E-mail: cyndrella.carvalho@centrum.co.in